Literature DB >> 31831852

MSI-H: a truly agnostic biomarker?

Peter Sidaway1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31831852     DOI: 10.1038/s41571-019-0310-5

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  2 in total

1.  Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study.

Authors:  Aurelien Marabelle; Dung T Le; Paolo A Ascierto; Anna Maria Di Giacomo; Ana De Jesus-Acosta; Jean-Pierre Delord; Ravit Geva; Maya Gottfried; Nicolas Penel; Aaron R Hansen; Sarina A Piha-Paul; Toshihiko Doi; Bo Gao; Hyun Cheol Chung; Jose Lopez-Martin; Yung-Jue Bang; Ronnie Shapira Frommer; Manisha Shah; Razi Ghori; Andrew K Joe; Scott K Pruitt; Luis A Diaz
Journal:  J Clin Oncol       Date:  2019-11-04       Impact factor: 44.544

2.  Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164.

Authors:  Dung T Le; Tae Won Kim; Eric Van Cutsem; Ravit Geva; Dirk Jäger; Hiroki Hara; Matthew Burge; Bert O'Neil; Petr Kavan; Takayuki Yoshino; Rosine Guimbaud; Hiroya Taniguchi; Elena Elez; Salah-Eddin Al-Batran; Patrick M Boland; Todd Crocenzi; Chloe E Atreya; Yi Cui; Tong Dai; Patricia Marinello; Luis A Diaz; Thierry André
Journal:  J Clin Oncol       Date:  2019-11-14       Impact factor: 44.544

  2 in total
  5 in total

1.  Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumors.

Authors:  Mohamed E Salem; J Nicholas Bodor; Alberto Puccini; Joanne Xiu; Richard M Goldberg; Axel Grothey; W Michael Korn; Anthony F Shields; William M Worrilow; Edward S Kim; Heinz-Josef Lenz; John L Marshall; Michael J Hall
Journal:  Int J Cancer       Date:  2020-06-18       Impact factor: 7.396

Review 2.  Precision oncology in metastatic colorectal cancer - from biology to medicine.

Authors:  Federica Di Nicolantonio; Pietro Paolo Vitiello; Silvia Marsoni; Salvatore Siena; Josep Tabernero; Livio Trusolino; Rene Bernards; Alberto Bardelli
Journal:  Nat Rev Clin Oncol       Date:  2021-04-16       Impact factor: 66.675

Review 3.  Artificial Intelligence in Cancer Research and Precision Medicine.

Authors:  Bhavneet Bhinder; Coryandar Gilvary; Neel S Madhukar; Olivier Elemento
Journal:  Cancer Discov       Date:  2021-04       Impact factor: 38.272

Review 4.  An Insight on Novel Molecular Pathways in Metastatic Prostate Cancer: A Focus on DDR, MSI and AKT.

Authors:  Veronica Mollica; Andrea Marchetti; Matteo Rosellini; Giacomo Nuvola; Alessandro Rizzo; Matteo Santoni; Alessia Cimadamore; Rodolfo Montironi; Francesco Massari
Journal:  Int J Mol Sci       Date:  2021-12-16       Impact factor: 5.923

Review 5.  Therapy of Primary Liver Cancer.

Authors:  Mei Feng; Yisheng Pan; Ruirui Kong; Shaokun Shu
Journal:  Innovation (Camb)       Date:  2020-08-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.